SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection
- PMID: 25843190
- PMCID: PMC4392576
- DOI: 10.4103/1319-3767.153810
SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection
Comment in
-
Ribavirin-free treatment may soon be a reality.Saudi J Gastroenterol. 2015 Jul-Aug;21(4):260-1. doi: 10.4103/1319-3767.161633. Saudi J Gastroenterol. 2015. PMID: 26228372 Free PMC article. No abstract available.
-
Hepatitis C position statement: Taking a stand and standing by it.Saudi J Gastroenterol. 2015 Jul-Aug;21(4):262-3. doi: 10.4103/1319-3767.161637. Saudi J Gastroenterol. 2015. PMID: 26228373 Free PMC article. No abstract available.
-
Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients.Saudi J Gastroenterol. 2017 Jul-Aug;23(4):263-264. doi: 10.4103/sjg.SJG_136_17. Saudi J Gastroenterol. 2017. PMID: 28721982 Free PMC article. No abstract available.
References
-
- Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–42. - PubMed
-
- Alswaidi FM, O'Brien SJ. Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors? J Epidemiol Community Health. 2010;64:989–97. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical